These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21501418)

  • 21. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells.
    Löwer R; Löwer J; Tondera-Koch C; Kurth R
    Virology; 1993 Feb; 192(2):501-11. PubMed ID: 8421897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence variability of retroviral particles derived from human melanoma cells melanoma-associated retrovirus.
    Hirschl S; Schanab O; Seppele H; Waltenberger A; Humer J; Wolff K; Pehamberger H; Muster T
    Virus Res; 2007 Feb; 123(2):211-5. PubMed ID: 17005285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
    Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y
    J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses.
    Tönjes RR; Boller K; Limbach C; Lugert R; Kurth R
    Virology; 1997 Jul; 233(2):280-91. PubMed ID: 9217052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.
    Krone B; Kölmel KF; Henz BM; Grange JM
    Eur J Cancer; 2005 Jan; 41(1):104-17. PubMed ID: 15617995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis.
    Molès JP; Tesniere A; Guilhou JJ
    Br J Dermatol; 2005 Jul; 153(1):83-9. PubMed ID: 16029331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.
    Katoh I; Mírová A; Kurata S; Murakami Y; Horikawa K; Nakakuki N; Sakai T; Hashimoto K; Maruyama A; Yonaga T; Fukunishi N; Moriishi K; Hirai H
    Neoplasia; 2011 Nov; 13(11):1081-92. PubMed ID: 22131883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion.
    Gebhardt C; Averbeck M; Viertel A; Kauer F; Saalbach A; Anderegg U; Simon JC
    Exp Dermatol; 2007 Aug; 16(8):636-43. PubMed ID: 17620090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel gene from the human endogenous retrovirus K expressed in transformed cells.
    Armbruester V; Sauter M; Krautkraemer E; Meese E; Kleiman A; Best B; Roemer K; Mueller-Lantzsch N
    Clin Cancer Res; 2002 Jun; 8(6):1800-7. PubMed ID: 12060620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human endogenous retrovirus K (HERV-K) rec mRNA is expressed in primary melanoma but not in benign naevi or normal skin.
    Singh S; Kaye S; Francis N; Peston D; Gore M; McClure M; Bunker C
    Pigment Cell Melanoma Res; 2013 May; 26(3):426-8. PubMed ID: 23311654
    [No Abstract]   [Full Text] [Related]  

  • 31. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).
    Lavie L; Kitova M; Maldener E; Meese E; Mayer J
    J Virol; 2005 Jan; 79(2):876-83. PubMed ID: 15613316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines.
    Zeilfelder U; Frank O; Sparacio S; Schön U; Bosch V; Seifarth W; Leib-Mösch C
    Gene; 2007 Apr; 390(1-2):175-9. PubMed ID: 17045761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human endogenous retroviruses and cancer prevention: evidence and prospects.
    Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
    BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HERV-K-T47D-Related long terminal repeats mediate polyadenylation of cellular transcripts.
    Baust C; Seifarth W; Germaier H; Hehlmann R; Leib-Mösch C
    Genomics; 2000 May; 66(1):98-103. PubMed ID: 10843810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of porcine endogenous retroviruses (PERVs) in melanomas of Munich miniature swine (MMS) Troll.
    Dieckhoff B; Puhlmann J; Büscher K; Hafner-Marx A; Herbach N; Bannert N; Büttner M; Wanke R; Kurth R; Denner J
    Vet Microbiol; 2007 Jul; 123(1-3):53-68. PubMed ID: 17418507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma.
    Wang-Johanning F; Frost AR; Jian B; Azerou R; Lu DW; Chen DT; Johanning GL
    Cancer; 2003 Jul; 98(1):187-97. PubMed ID: 12833471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of HERV-K env gene expression and splicing in human breast cancer.
    Wang-Johanning F; Frost AR; Jian B; Epp L; Lu DW; Johanning GL
    Oncogene; 2003 Mar; 22(10):1528-35. PubMed ID: 12629516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review: human endogenous retroviruses and the placenta.
    Sugimoto J; Schust DJ
    Reprod Sci; 2009 Nov; 16(11):1023-33. PubMed ID: 19474286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer.
    Rezaei SD; Hayward JA; Norden S; Pedersen J; Mills J; Hearps AC; Tachedjian G
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
    Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C
    J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.